CCT196969 - Moligand™, ≥98% , Inhibitor of B-Raf proto-oncogene; serine/threonine kinase;Inhibitor of LCK proto-oncogene; Src family tyrosine kinase;Inhibitor of Raf-1 proto-oncogene; serine/threonine kinase;Inhibitor of SRC proto-oncogene; non-receptor t, Inhibitor of B-Raf proto-oncogene; serine/threonine kinase;Inhibitor of LCK proto-oncogene; Src family tyrosine kinase;Inhibitor of Raf-1 proto-oncogene; serine/threonine kinase;Inhibitor of SRC proto-oncogene; non-receptor tyrosine kinase

CAS: 1163719-56-9 Cat. No.: C413825 Summenformel: C27H24FN7O3 Molekulargewicht: 513.52
Zu bestellen verfügbar
QUALITÄT & REINHEIT Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools. ≥98%
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
★
Größe
Deutschland (EU)
USA*
Preis
Menge
5mg
C413825-5mg
—
5 Auf Lager
72,80€
10mg
C413825-10mg
—
5 Auf Lager
138,75€
25mg
C413825-25mg
—
2 Auf Lager
294,94€
50mg
C413825-50mg
—
2 Auf Lager
520,56€
100mg
C413825-100mg
—
2 Auf Lager
937,07€
Enter a quantity for the sizes you want to add.

Übersicht

Information

CCT196969 is a novel orally available, pan-RAFinhibitor with anti-SRCactivity. It also inhibits SRC, LCK, and the p38 MAPKs.


Targets

CRAF (Cell-free assay); LCK (Cell-free assay); Src (Cell-free assay); V600E-BRAF (Cell-free assay); BRAF (Cell-free assay) ;0.01 μM; 0.02 μM; 0.03 μM; 0.04 μM; 0.1 μM


In vitro

CCT196969 is active against melanoma and colorectal cancer cell lines that are mutant for BRAF, but not cancer cells that are wild-type for BRAF and NRAS. CCT196969 induces caspase 3 and PARP cleavage, thus induces apoptosis. CCT196969 does not drive paradoxical pathway activation and inhibit MEK/ERK in BRAF and NRAS mutant melanoma.


In vivo

CCT196969 is extremely well tolerated at the doses assessed and does not produce any significant adverse effects in vivo. Oral dosing at 10 mg/kg/day of CCT196969 results in plasma concentrations ∼1 μM at 24 hr. It is orally bioavailable at ∼55%.


Cell Research(from reference)

Cell lines:cell line derived from a vemurafenib-resistant melanoma 

Concentrations:1 μM 

Incubation Time:4 h 

Spezifikationen

Spezifikationen & Reinheit
Moligand™, ≥98%
Biochemische und physiologische Mechanismen
CCT196969 is a novel orally available, pan-RAF inhibitor with anti-SRC activity. It also inhibits SRC, LCK, and the p38 MAPKs.
Storage
Store at -20°C
Verschickt in
Ice chest + Ice pads
Dieses Produkt erfordert Kühlkettenversand. Grundversand und andere Economy-Optionen sind nicht verfügbar.
Note
Moligand™
Aktionsart
INHIBITOR
Mechanismus der Wirkung
Inhibitor of B-Raf proto-oncogene; serine/threonine kinase;Inhibitor of LCK proto-oncogene; Src family tyrosine kinase;Inhibitor of Raf-1 proto-oncogene; serine/threonine kinase;Inhibitor of SRC proto-oncogene; non-receptor tyrosine kinase
Reinheit
≥98%
Namen und Kennungen
Pubchem Sid
Pubchem Sid Url
https://pubchem.ncbi.nlm.nih.gov/substance/488200909
SMILES
CC(C)(C)C1=NN(C(=C1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C(=NC=C3)NC(=O)C=N4)F)C5=CC=CC=C5
IUPAC Name
1-(5-tert-butyl-2-phenylpyrazol-3-yl)-3-[2-fluoro-4-[(3-oxo-4H-pyrido[2,3-b]pyrazin-8-yl)oxy]phenyl]urea
InChIKey
KYYKGSDLXXKQCR-UHFFFAOYSA-N
InChI
1S/C27H24FN7O3/c1-27(2,3)21-14-22(35(34-21)16-7-5-4-6-8-16)32-26(37)31-19-10-9-17(13-18(19)28)38-20-11-12-29-25-24(20)30-15-23(36)33-25/h4-15H,1-3H3,(H,29,33,36)(H2,31,32,37)
Isomere SMILES
CC(C)(C)C1=NN(C(=C1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C(=NC=C3)NC(=O)C=N4)F)C5=CC=CC=C5
MeSH-Eintrag
1-(3-tert-butyl-1-phenyl-1H-pyrazol-5-yl)-3-(2-fluoro-4-(3-oxo-3,4-dihydropyrido(3,2-b)pyrazin-8-yloxy)phenyl)urea;CCT196969
Molekulargewicht
513.52
Reaxys
19328964
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=19328964&ln=

Erweiterte Daten

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassOrganoheterocyclic compounds
KlasseAzoles
SubclassPyrazoles
Intermediate Tree Nodes Not available
Direct ParentPhenylpyrazoles
Alternative Parents Diarylethers  Pyridopyrazines  N-phenylureas  Phenol ethers  Phenoxy compounds  Fluorobenzenes  Pyridines and derivatives  Aryl fluorides  Pyrazines  Heteroaromatic compounds  Lactams  Ureas  Azacyclic compounds  Organonitrogen compounds  Organofluorides  Organic oxides  Hydrocarbon derivatives  Carbonyl compounds  
Molecular FrameworkAromatic heteropolycyclic compounds
Substituents Diaryl ether - Phenylpyrazole - N-phenylurea - Pyridopyrazine - Phenoxy compound - Phenol ether - Halobenzene - Fluorobenzene - Aryl fluoride - Aryl halide - Monocyclic benzene moiety - Benzenoid - Pyridine - Pyrazine - Heteroaromatic compound - Urea - Lactam - Ether - Azacycle - Organonitrogen compound - Organooxygen compound - Organic nitrogen compound - Hydrocarbon derivative - Carbonyl group - Organic oxide - Organic oxygen compound - Organofluoride - Organohalogen compound - Aromatic heteropolycyclic compound
BeschreibungThis compound belongs to the class of organic compounds known as phenylpyrazoles. These are compounds containing a phenylpyrazole skeleton, which consists of a pyrazole bound to a phenyl group.
External Descriptors Not available
3D-Struktur
Interaktives chemisches Strukturmodell





Zugehörige Ziele (menschlich)
RAF1 Tclin RAF proto-oncogene serine/threonine-protein kinase (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
SRC Tclin Proto-oncogene tyrosine-protein kinase Src (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
LCK Tclin Tyrosine-protein kinase Lck (1 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
BRAF Tclin Serine/threonine-protein kinase B-raf (2 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
A-375 (9258 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BRAF Tclin Serine/threonine-protein kinase B-raf (11587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
WM 266-4 (208 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Zugehörige Ziele (nicht menschlich)
rep Replicase polyprotein 1ab (378 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Wirkungsmechanismen
Zertifikate (CoA, COO, BSE/TSE und Analyse-Diagramm)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

10 results found

Lot NumberCertificate TypeDatumArtikel
D2306106D2306106Certificate of AnalysisJan 21, 2026 C413825
D2306113D2306113Certificate of AnalysisJan 21, 2026 C413825
D2306114D2306114Certificate of AnalysisJan 21, 2026 C413825
D2306125D2306125Certificate of AnalysisJan 21, 2026 C413825
D2306126D2306126Certificate of AnalysisJan 21, 2026 C413825
D2306127D2306127Certificate of AnalysisJan 21, 2026 C413825
D2306130D2306130Certificate of AnalysisJan 21, 2026 C413825
D2306131D2306131Certificate of AnalysisJan 21, 2026 C413825
D2306132D2306132Certificate of AnalysisJan 21, 2026 C413825
D2306139D2306139Certificate of AnalysisFeb 09, 2023 C413825
Chemische und physikalische Eigenschaften
LöslichkeitSolubility (25°C) In vitro DMSO: 100 mg/mL (194.73 mM); Water: Insoluble; Ethanol: Insoluble;
Molekulargewicht513.5
XLogP34.200
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count7
Rotatable Bond Count6
Exact Mass513.192 Da
Monoisotopic Mass513.192 Da
Topological Polar Surface Area123.000 Ų
Heavy Atom Count38
Formal Charge0
Complexity877.000
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds0
Covalently-Bonded Unit Count1
Sicherheit und Gefahren (GHS)
Reaxys
19328964
Reaxys-RN_link_address
https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=19328964&ln=
Lösungsrechner
Bewertungen

Kundenbewertungen

Dürfen wir Sie über Rabattaktionen informieren?

Später erinnern

Vielen Dank! Bitte überprüfen Sie Ihren E-Mail-Posteingang, um zu bestätigen.

Hoppla! Benachrichtigungen sind deaktiviert.